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Dynamic changes in intrathymic ILC populations
during murine neonatal development
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Members of the innate lymphoid cell (ILC) family have been implicated in the develop-
ment of thymic microenvironments and the recovery of this architecture after damage.
However, a detailed characterization of this family in the thymus is lacking. To bet-
ter understand the thymic ILC compartment, we have utilized multiple in vivo models
including the fate mapping of inhibitor of DNA binding-2 (Id2) expression and the use of
Id2 reporter mice. Our data demonstrate that ILCs are more prominent immediately after
birth, but were rapidly diluted as the T-cell development program increased. As observed
in the embryonic thymus, CCR6+NKp46− lymphoid tissue inducer (LTi) cells were the
main ILC3 population present, but numbers of these cells swiftly declined in the neonate
and ILC3 were barely detectable in adult thymus. This loss of ILC3 means ILC2 are the
dominant ILC population in the thymus. Thymic ILC2were able to produce IL-5 and IL-13,
were located within the medulla, and did not result from ILC3 plasticity. Furthermore, in
WT mice, thymic ILC2 express little RANKL (receptor activator of nuclear factor kappa-B
ligand) arguing that functionally, these cells provide different signals to LTi cells in the
thymus. Collectively, these data reveal a dynamic switch in the ILC populations of the
thymus during neonatal development.
Keywords: Innate lymphoid cells  Lymphoid tissue  Neonate  RORγt  Thymus
See accompanying commentary by Tom Cupedo
 Additional supporting information may be found online in the Supporting Information sectionat the end of the article.
Introduction
Innate lymphoid cells (ILC) have been described in many tis-
sues [1, 2] and it seems likely that this family of cells is present
essentially throughout the body. However, it is clear that the pre-
cise composition of these cells is often highly tissue specific and
Correspondence: Dr. David R. Withers
e-mail: d.withers@bham.ac.uk
also developmentally regulated. Within the embryo, lymphoid tis-
sue inducer (LTi) cells comprise the RORγt-dependent group 3 ILC
(ILC3) population and these cells appear, required for the estab-
lishment of secondary lymphoid tissues such as lymph nodes and
Peyer’s patches [3], through orchestrating recruitment of lympho-
cytes to the developing anlagen after LTi cell:stromal cell interac-
tions [4]. Notably, LTi cells were also identified within the embry-
onic thymus where they again interact with stroma to establish
a lymphoid microenvironment, in this case providing receptor
C© 2018 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co.
KGaA, Weinheim.
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activator of nuclear factor kappa-B ligand (RANKL) to developing
medullary thymic epithelial cells (mTEC) [5]. Thus in both pri-
mary and secondary lymphoid tissues, members of the ILC3 family
play a key role in the generation of tissue microenvironments that
support lymphocyte maturation and subsequent responses. Given
the importance of lymphoid tissue microenvironments to normal
function, recovery of such architecture is rapidly induced follow-
ing damage and ILC3 have also been implicated in this process in
both primary and secondary lymphoid tissue [6, 7]. Recovery of
splenic architecture after viral infection was impaired in Rorc−/−
mice [6], while ILC3 have been identified as a key source of IL-22
after radiation induced thymic damage [7]. While the ILC com-
partment of secondary lymphoid tissues has been described in
several studies [8, 9], characterization of ILC populations in the
thymus has not been performed in detail, perhaps impeded by the
phenotypic similarities between ILC and developing thymocytes.
In addition to the descriptions of ILC3, ILC2 have also been iden-
tified in both mouse and human thymus [10–13], although their
location within the tissue and their function remain unclear. Fur-
thermore, whether the ILC populations in the thymus change over
time has not been addressed. Here we have undertaken a detailed
characterization of thymic ILC from birth through to adulthood
using several in vivo models to ensure discrimination of ILC from
developing thymocytes. While we could clearly detect ILC3 with
an LTi cell phenotype in embryonic and neonatal thymus, surpris-
ingly we found that ILC3 rapidly declined in number after birth.
In contrast, ILC2 gradually increased in the thymus over time.
These cells were located within the medulla of the thymus, were
functional in terms of their capacity to make IL5 and IL-13, and
lacked expression of RANKL, a molecule thought to be critical for
LTi cell function in the developing thymus. Collectively, our data
reveal that while ILC3 function to establish the thymic medulla,
ILC2 become the dominant ILC population within the thymus after
birth and likely support normal thymic function through type 2
cytokine release.
Results
ILC populations in the neonatal thymus
LTi cells were originally identified within the embryonic thymus
more than 10 years ago [5]. Since the discovery of LTi cells, it
is now understood that these cells belong to the ILC family, with
inclusion in this family dependent upon a clearly described pheno-
type and function [2]. Given these advances, we wanted to reex-
amine the ILC populations within the embryonic thymus and asked
whether any other ILC populations beyond LTi cells were present.
To do this, we established fetal thymic organ cultures using embry-
onic day 16 thymi. After 7 days in culture, fetal thymic organ cul-
tures were disaggregated and ILC populations were assessed by
flow cytometry. ILC were defined as IL-7Rα+Lin−CD8α− intracel-
lular CD3− (CD3i−) cells with ILC2 and ILC3 identified on the
basis of expression of the transcription factors GATA-3 and RORγt
(Supporting Information Fig. 1). In addition to a clear LTi cell
population (RORγt+CCR6+NKp46−CD4+/−), a smaller, but dis-
tinct population of RORγt−GATA-3+ ILC2 was evident, indicating
that multiple ILC populations or at least their progenitors exist
within the embryonic thymus after ex vivo culture condition.
To understand whether these embryonic ILC populations were
maintained after birth, we characterized ILC populations in the
thymus at different ages (Fig. 1A). The neonatal thymus con-
tained a mixture of ILC3 and ILC2 populations in similar propor-
tions during the first week of life; however, by 2 weeks of age, the
proportion of ILC that expressed RORγt had decreased sharply
and very few ILC3 (<5% ILC population) were detected from this
age onwards (Fig. 1A and B). The proportion of ILC among total
thymocytes was highest at birth (0.05% of total thymocytes) but
then rapidly declined, such that by 2 weeks of age, ILC formed
a tiny (<0.001%) proportion of all thymocytes (Fig. 1C). Total
numbers of ILC had actually increased between birth and 2 weeks
of age (Fig. 1D), largely due to an increase in the total number
of ILC2 (Fig. 1E). Total numbers of ILC3 had declined by 2 weeks
of age and we could detect <50 ILC3 within an entire adult thy-
mus (Fig. 1E). Having identified ILC2 and ILC3 populations, we
additionally stained for expression of T-bet to identify ILC1 in the
thymus. At 7 and 14 days postbirth, a distinct ILC1 population
was evident (Fig. 1F–H), demonstrating that the neonatal thymus
contains all the ILC subsets. Notably, a population of ILC based on
IL-7Rα expression in the absence of expression of an extensive
panel of lineage markers was also observed (Fig. 1F–H), con-
sistent with a recent report identifying such cells in multiple
tissues [14]. In this report, prolonged enzymatic digestion was
shown to increase the frequency of these cells prompting concerns
as to their exact nature; however, here the thymus was disaggre-
gated using only mechanical means. Combined these data indi-
cate that after birth, the ILC3 compartment is gradually lost while
a small ILC2 population is maintained through to adult hood.
Phenotypically, the ILC2 in the neonatal thymus expressed little
KLRG-1, but did express ICOS and ST2, while the majority of the
ILC3 compartment phenotypically resembled the CCR6+NKp46−
LTi cells observed in the embryo (Fig. 1I and J and Supporting
Information Fig. 2).
Identification of ILCs in the adult thymus
ILC have a surface phenotype highly similar to T cells with the
key exception of the TCR and associated signaling molecules.
Given the variable expression of the TCR at different stages of
thymocyte development, we considered that correct identifica-
tion of ILC within adult thymus might be challenging using sur-
face markers alone. Thus, we sought to confirm our initial data
on ILC populations within the adult thymus and hypothesized
that identification of cells that were fate mapped for inhibitor
of DNA binding-2 (Id2) expression would facilitate identification
of ILC, since Id2 is a key transcription factor expressed by ILC
progenitors [15, 16] but largely absent in, and not required by,
developing thymocytes [17]. To test this, we first assessed the
ILC population detectable in the mesenteric lymph node (mLN)
C© 2018 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 1. Characterization of thymic neonatal ILC populations. To assess the nature of ILC populations in the neonatal thymus, these cells were
characterized at 1, 7, and 14 days postbirth and in adulthood (6–12 weeks) by flow cytometry. (A) Representative flow cytometry plots showing
analysis of thymic ILC identified as CD8α−CD3i−IL-7Rα+Lin− (B220, CD3, CD5, CD11b, and CD11c) cells with ILC2 (GATA-3+) and ILC3 (RORγt+)
gated. (B) The proportion of ILC2 and ILC3 as a percentage of the total thymic ILC population. (C) The proportion of ILC as a percentage of total
thymocytes. The total number of ILC (D) and the total number of ILC2 and ILC3 (E) in the thymus at different ages. (F) Representative flow cytometry
plots showing analysis of thymic ILCs identified as CD8α−CD3i−IL-7Rα+extended-Lin− (B220, CD3, CD5, CD11b, CD11c, CD19, CD49b, CD123, F4/80,
FcεR1, Gr-1, and Ter119) cells with ILC1 (Tbet+), ILC2 (GATA-3+), ILC3 (RORγt+), and “triple negative” ILC (‘TrN’; GATA-3−RORγt−Tbet−) gated in
the neonatal thymus at 7 days postbirth. The proportion (G) and total number (H) of ‘TrN’ ILC and ILC1 in the neonatal thymus at 7and 14 days
postbirth. (I) The median fluorescence intensity (MFI) of KLRG-1, ICOS, and ST2 expression by ILC2 isolated from neonatal thymus and adult lung.
(J) The proportion and total number of CCR6+NKp46− and CCR6−NKp46+ ILC3 subsets in the neonatal thymus at 7 days postbirth. Mann–Whitney
U-test (comparing two samples) or a one-way ANOVA (comparing three ormore samples) was used for statistical analysis where *p< 0.05, **p< 0.01,
***p < 0.001, and ****p < 0.0001. In all graphs, the bar represents the median, n = 9 for day 1, n = 7 for day 7, n = 7 for day 14, and n = 7 for adulthood
(apart from in F–H, where n = 8 for day 7 and n = 6 for day 14), with data (in panels B, C, D, E, G, H, I, and J) pooled from at least two independent
experiments at each age. Full gating strategy for all flow cytometry data identifying thymic ILC populations is shown in Supporting Information
Fig. 1A.
C© 2018 The Authors. European Journal of Immunology published by
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Figure 2. Analysis of thymic ILC populations through fate mapping Id2 expression. To aid identification of thymic ILC populations, Id2creERT2 ×
ROSAmT/mG mice were used to fate map Id2 expression. Administration of tamoxifen by oral gavage on five consecutive days was performed and
ILC populations in the thymus and mLN analyzed 3 days later by flow cytometry. (A) Full gating strategy for flow cytometry data showing analysis
of IL-7Rα+Lin−CD3i− cells gated on all lymphocytes (upper panels) versus pregating on mGreen+ Id2 fate-mapped cells (lower panels) among mLN
cells. (B) The proportion of ILC in the mLN with and without gating on Id2 fate-mapped (mGreen+) cells. (C) Representative flow cytometry plots
showing analysis of IL-7Rα+Lin− CD3i− cells from total cells (upper panels) versus pregating on mGreen+ Id2 fate-mapped cells (lower panels)
among thymus cells. (D) The proportion of ILC in the thymus with and without gating on Id2 fate-mapped (mGreen+) cells. The proportion (E) and
total number (F) of ILC2 and ILC3 in the mLN and thymus of Id2creERT2 × ROSAmT/mG mice. Mann–Whitney U-test was used for statistical analysis,
where *p < 0.05 and **p < 0.01. In all graphs, the bar represents the median, n = 5, data (in panels B, D, E, and F) were pooled from two independent
experiments.
of Id2creERT2 × ROSAmT/mG mice after tamoxifen administration
by oral gavage (Fig. 2A). Comparing the ILC populations among
total lymphocytes and those fate mapping for expression of Id2
(mGreen+), it was evident that prior gating on cells that were
fate mapped for Id2 expression increased the proportion of IL-
7Rα+ Lin− cells approximately 30-fold (Fig. 2B), indicating that
this approach could indeed facilitate identification of ILC. Impor-
tantly, the proportions of ILC2 and ILC3 identified through these
gating strategies remained highly comparable. We then applied
this gating approach to the identification of thymic ILC, which
revealed a small fate-mapped IL-7Rα+Lin− population in the thy-
mus (Fig. 2C). While pregating on Id2-fate-mapped cells did not
increase the proportion of ILC we identified, it did enable a more
clear demarcation of a distinct IL-7Rα+Lin− population (Fig. 2C
and D). Analysis of the adult thymus in Id2creERT2 × ROSAmT/mG
mice after tamoxifen showed that ILC3 were indeed a tiny propor-
tion (<5%) of the ILC population in the thymus (Fig. 2D and E). To
enumerate these ILC populations, the efficiency of ILC fate map-
ping in themLNwas first calculated and then used to generate total
numbers in the thymus assuming comparable cre induction. Using
C© 2018 The Authors. European Journal of Immunology published by
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Figure 3. Analysis of thymic ILC in Id2-eGFP reporter mice. To directly assess Id2 expressing ILC populations in the thymus andmLN, these tissues
from Id2-eGFP mice were analyzed by flow cytometry. (A) Full gating strategy for flow cytometry used to identify GATA3+ ILC2 and RORγt+ ILC3
among eGFP+ cells isolated from the mLN and thymus. (B) Gating controls for eGFP+ cells were based upon thymocytes from C57BL/6 WT mLN
and thymus. (C) The percentage of eGFP+ ILC (CD8α−CD3i−IL-7Rα+Lin− cells) as a proportion of total cells isolated from thymus and mLN. (D)
The percentage of eGFP+ ILC2 and ILC3 as a proportion of total ILC isolated from thymus and mLN. Mann–Whitney U-test was used for statistical
analysis, where ***p < 0.001, bars show medians, n = 7 for thymus and mLN. Data were pooled from two independent experiments.
this quantitation, we could again detect a median of <50 ILC3 per
adult thymus, while the total number of ILC2 in the thymus was
comparable to that detected in the mLN (Fig. 2F). An alternative
approach administering tamoxifen for a longer period of time via
the diet enabled an increased proportion of ILC to be fate mapped,
however, the datawas comparable in terms of the ILC subsets iden-
tified within the thymus (Supporting Information Fig. 3). Collec-
tively, these experiments reveal that fate mapping Id2 expression
does enhance our ability to identify ILC and within the adult thy-
mus, the majority of ILC are not ILC3, but rather GATA-3+ ILC2.
While assessing the cells in the thymus that fate mapped for Id2
expression, it was evident that the vast majority of these cells were
not ILC. Using Id2creERT2 × ROSA26tdRFP mice given tamoxifen by
oral gavage for 5 days, we identified that the majority of thymic
cells that were fate mapped (RFP+) expressed TCRβ+ (Supporting
Information Fig. 4). Furthermore, it was observed that oral gav-
age with tamoxifen resulted in a substantial decline in thymocyte
cellularity and double-positive thymocytes were found to be par-
ticularly sensitive to administration of tamoxifen in this manner
(Supporting Information Fig. 5). Analysis of ILC within the mLN
revealed only a modest decrease in these cells indicating that the
very low numbers of ILC detected in the thymus of Id2creERT2 ×
ROSAmT/mG mice were not solely due to the effects of tamoxifen
treatment (Supporting Information Fig. 4).
To further analyze ILC populations using Id2 expression, but in
the absence of tamoxifen administration, the ILC compartment in
the mLN and thymus of Id2-eGFP reporters was assessed (Fig. 3A).
Cells isolated fromWTmice (and thus eGFP−) were used to enable
gating on eGFP+ populations (Fig. 3B). In the mLN, gating on
eGFP+ cells enabled clear identification of ILC populations com-
parable to those described in the adult mLN [8]. Consistent with
the data from Id2creERT2 × ROSAmT/mG mice, only a very small pop-
ulation of eGFP+Lin− cells was detected in the thymus (Fig. 3A
and C) and after gating on IL-7Rα+ cells, ILC populations compa-
rable to previous experiments were detected and arguing against
an artefact of tamoxifen administration (Fig. 3A and D). Thus,
using prior or current expression of Id2 to aid ILC identification,
the data show that the adult thymus contains a small population
of ILC in which ILC2 are far more numerous than ILC3.
ILC2 are located in the thymic medulla
Having characterized the ILC populations of the thymus, we
wanted to better understand the location of these cells and what
signals within the thymic microenvironment impacted on their
development and persistence. Analysis of ILC in sections of lym-
phoid tissue is challenging given the abundance of T cells, which
likely surround ILC populations and hinder identification of non-T
cells. Thus, we reasoned that it would be easier to identify ILC
populations in the thymus using TCRα−/− mice and here we could
clearly identify putative ILC2 (GATA-3+CD3−IL-7Rα+) scattered
C© 2018 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 4. ILC2 reside within the medulla in the TCRα−/− thymus. To investigate the location of ILC2 within the thymus, frozen sections of TCRα−/−
thymus were assessed for expression of (A) GATA-3, CD3, and IL-7Rα and (B) GATA-3, CD3, and ICOS using immunofluorescence. Sections were
counterstained with DAPI, data representative of tissue from three mice, putative ILC2 encircled in white. Scale bar: 50μm. (C) Sections of WT
neonatal thymus assessed for expression of GATA-3, CD3, and IL-7Rα. Sections were counterstained with DAPI, data representative of tissue
from three mice, scale bar represents putative ILC2 encircled in white. Scale bar: 100μm. (D) Total numbers of ILC2 and ILC3 isolated from
TCRα−/− thymus, TCRα−/- mLN, and WTmLN. (E) Representative flow cytometry plots showing expression of IL-5 versus IL-13 by ILC2 after ex vivo
stimulation, alongside FMO control. Cells isolated from TCRα−/− thymus, mLN, and lung were compared. (F) The proportion of ILC2 isolated from
the thymus, mLN, or lung expressing IL-13 and IL-5 after ex vivo stimulation. Bars show medians, n = 9 for TCRα−/− thymus and TCRα−/− mLN,
and n = 6 for WT mLN (C). n = 6 for thymus, mLN, and lung (D, E, and F). Mann–Whitney U-test (comparing two samples) or a one-way ANOVA
(comparing three or more samples) was used for statistical analysis, where *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. Data were pooled
from two independent experiments. Full gating strategy for all the flow cytometry data used to identify ILC in TCRα−/− mice shown in Supporting
Information Fig. 6A.
within the medulla using immunofluorescence (Fig. 4A). Analysis
of ICOS expression identified a similar population (this time
GATA-3+CD3−ICOS+ cells) within the thymic medulla (Fig. 4B)
providing further evidence that these cells were indeed ILC2.
Staining of 7 day old WT thymus for expression of GATA-3+,
CD3− and IL-7Rα+ again identified putative ILC2 in the medulla
indicating that this location was true of both TCRα−/− and WT
thymi (Fig. 4C). Flow cytometric analysis of the ILC populations
within the TCRα−/− thymus confirmed that the majority of ILC
belonged to the ILC2 group (Fig. 4D). Thus, normal medullary
development, which is impaired in the absence of single positive
CD4 T cells, is not required for the predominance of ILC2 among
ILC populations in the thymus. To confirm that thymic ILC2
were able to express the signature cytokines associated with ILC2
function, ex vivo stimulations were performed and expression
of both IL-5 and IL-13 detected (Fig. 4E and F). As observed
in the mLN previously [8], ILC numbers were elevated within
the TCRα−/− thymus, but the vast majority remained ILC2 and
the surface phenotype was consistent with that observed in the
neonate (Supporting Information Fig. 6). The few thymic ILC
that expressed RORγt also expressed CCR6 and were a mixture
of CD4+/− cells, consistent with the LTi-like subset.
ILC2 expansion in the thymus is not due to ILC3
plasticity
Recent studies have identified plasticity among ILC populations,
particularly within the ILC3 subset, where in vivo fate mapping
studies have revealed that some ILC3 lose expression of RORγt
C© 2018 The Authors. European Journal of Immunology published by
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Figure 5. ILC3 plasticity does not account for increase in thymic ILC populations post birth. To test whether the loss of thymic ILC3 after birth
could be attributed to differentiation to another ILC type, RORγt expression was fate mapped using Rorccre × ROSAmT/mG mice and cells analyzed
by flow cytometry. (A) Full gating strategy for flow cytometry data identifying mGreen+ (fate mapped) and mGreen− populations among ILC
(CD8−CD3i−IL-7Rα+Lin−) in the mLN and thymus. (B) Enumeration of thymic ILC showing putative ILC1 (GATA3−RORγt−), ILC2 (GATA3+), and ILC3
(RORγt+) comparing numbers of each population among total ILC versus mGreen+ ILC. Mann–Whitney U-test was used for statistical analysis,
where *p < 0.05. Bars show medians, n = 8, pooled from two independent experiments.
to become “ex-ILC3,” a population very similar to IFNγ+Tbet+
ILC1 [18]. Thus, it was conceivable that the loss of ILC3 in the
thymus reflected plasticity during neonatal development with the
RORγt-expressing ILC population switching to another fate. To
test whether ILC3 populations in the thymus show evidence of
plasticity, we fate mapped RORγt expression in thymic ILC using
Rorccre × ROSAmT/mG mice and looked at mGreen expression in
the thymus and mLN. While the majority of ILC in the mLN were
mGreen+, reflecting the large number of ILC3 in this tissue [8],
only a minority of ILC (20%) in the thymus were mGreen+
(Fig. 5A). Analysis of RORγt expression at the protein level using
intracellular flow cytometry revealed a clear “ex-ILC3” population
in both the mLN and the thymus (mGreen+ but RORγt−). Enumer-
ation of the number of total versus mGreen+ ILC populations made
it clear that the vast majority of thymic ILC showed no evidence
of previous expression at the Rorc locus, arguing against ILC3
plasticity accounting for the loss of ILC3 and the increase in ILC2
(Fig. 5B).
ILC expression of RANKL in the neonatal thymus
The data described here reveal that the ILC compartment of the
thymus changes after birth with a substantial decline in ILC3
number and increased numbers of ILC2. Given the increase in
ILC2 numbers that coincided with the loss of ILC3 and the evi-
dence that ILC3 exist in the medulla [5], we postulated that ILC2
numbers might be enhanced in the absence of ILC3. To test this,
we analyzed ILC populations in the thymus of WT and Rorc−/−
mice. Within the adult thymus, ILC2 numbers were significantly
enhanced (>2-fold) compared to WT controls (Fig. 6A). This
increase in number was also evident in the neonate (Fig. 6B).
While these data are consistent with competition for a medullary
niche, the perturbations to T-cell development in Rorc−/− mice
mean that ILC intrinsic versus T-cell-dependent effects cannot be
distinguished. The ILC3 population in the thymus prebirth has
been implicated in mTECmaturation through provision of RANKL.
While after birth T cells are considered likely cellular providers of
RANKL to mTEC, we assessed RANKL expression among neona-
tal thymic ILC3 and ILC2 to test whether ILC2 might provide
RANKL after the decline in ILC3 numbers. Using adult mLN cells
as a positive control for RANKL expression, robust RANKL expres-
sion was detected on neonatal ILC3, however there was very lit-
tle detected on ILC2 (Fig. 6C–F). These data indicate that the
expanding ILC2 population in the thymus do not take over the
provision of RANKL to mTEC as ILC3 decline. Surprisingly, how-
ever, significantly enhanced expression of RANKL was detected
on ILC2 in the neonatal thymi of Rorc−/− mice, suggesting that
C© 2018 The Authors. European Journal of Immunology published by
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Figure 6. Neonatal ILC3, but not ILC2
express RANKL. To investigate the effect
of Rorc−/− deletion on thymic ILC popula-
tions, ILC2 and ILC3 were enumerated in
WT and Rorc−/− thymi. Numbers of ILC
(IL-7Rα+Lin−CD8−CD3i−), ILC2 (GATA-3+), and
ILC3 (RORγt+) detected in adult (A) and 7-
day-old neonatal (B) thymus. n = 7 adult
WT, 10 adult Rorc−/−, four neonatal WT, and
five neonatal Rorc−/−. Expression of RANKL
versus RORγt (C) and GATA-3 (D) by ILC
(IL-7Rα+Lin−CD8−CD3i−) from adult mLN
(upper panel) and neonatal thymus (lower
panel) assessed by flow cytometry. (E) Stain-
ing control of SA-PECy7 only with ILC2 and
ILC3 from adult mLN. (F) The percentage of
ILC2 and ILC3 expressing RANKL in the neona-
tal thymus, n = 7. (G) Expression of RANKL
by GATA-3+ ILC2 from WT (upper panels)
and Rorc−/− (lower panels) 14-day-old neona-
tal thymus. (H) Controls for RANKL showing
positive staining of RANKL by ILC from the
mLN and the negative control (SA-PECy7 only)
for neonatal thymus. (I) The percentage of
ILC2 isolated from WT and Rorc−/− neonatal
thymus that express RANKL, n = 8. Mann–
Whitney U-test was used for statistical analy-
sis, where **p< 0.01, bars showmedians. Data
were pooled from two (A, C, D, and F) and one
(B and G) independent experiments. Full gat-
ing strategy for all flow cytometry identifying
thymic ILC populations is shown in Support-
ing Information Fig. 1A.
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ILC2 can express RANKL when the thymic microenvironment is
perturbed.
Discussion
Here we provide the first detailed characterization of ILC in the
thymus, utilizing several in vivo models to facilitate accurate iden-
tification of these cells. Building on the earlier observation that LTi
cells populate the embryonic thymus and orchestrate mTEC mat-
uration through RANK:RANKL interactions, we demonstrate that
after birth, LTi cells decline during neonatal development while
ILC2 increase in number and become the main ILC population
present within the thymus. We provide evidence that thymic ILC2
are able to produce the signature cytokines IL-5 and IL-13 and
reside in the medulla where they may compete for an environ-
mental niche with ILC3. Finally, we show that thymic ILC2 do not
express RANKL under normal conditions, and thus appear to have
distinct functions to thymic LTi cells during embryonic develop-
ment.
ILC have been characterized within most tissues; however, to
date a clear description of the thymic ILC compartment has been
lacking. Discrimination between ILC and developing thymocytes
where TCR expression is reduced is technically challenging, but
this problem was resolved through analyzing expression of Id2
given its fundamental role in ILC development and redundant
role in αβ TCR+ T cell development [17]. Using both fate map-
ping and reporting of Id2 expression, our data clearly identify
thymic ILC, but reveal that these cells account for less than 0.05%
of the hematopoietic compartment of the thymus after birth and
less than 0.001% in the adult thymus. Thus, ILC are certainly a rare
population in the thymus. Functionally, LTi cells in the embryonic
thymus provide the RANKL signals required for mTEC maturation.
It is now evident that RANKL can be provided by other cells in the
developing embryonic thymus [19] and after birth, single-positive
thymocytes alongside other T cell populations contribute to a com-
plex network of signals governing mTEC development [20–22].
Thus, the loss of LTi cells in the neonatal thymus is consistent
with changes in the cellular interactions that govern mTEC mat-
uration. Our data would argue that while ILC2 reside within the
medulla, they are unlikely to contribute to mTEC maturation via
RANKL provision. Thus, the role for ILC in establishing thymic
microenvironments is restricted to early embryonic development.
What then do ILC2 contribute to thymic function? Based on
the array of studies in other tissues, it is reasonable to hypothesize
that ILC2 in the thymus are a local source of type 2 cytokines. Type
2 cytokines from iNKT cells were recently shown to control thymic
emigration of conventional thymocytes [23], and it is possible that
ILC2 may also contribute to this cytokine milieu. Whether ILC2
have unique functions within the thymus, or redundancy with
other innate populations also able to produce similar cytokines
such as iNKT cells requires further study, including the specific
deletion of ILC2 [24]. Since mice lacking ILC3 had increased
numbers of ILC2 within the thymus, there may be intrathymic
competition among ILC for residency within the tissue. However,
it is possible that the impaired T cell development caused by Rorc
deficiency may also contribute to enhanced ILC2 numbers, partic-
ularly since a similar increase in thymic ILC2 was observed in the
TCRα−/− thymus, where numbers of single-positive thymocytes
are obviously greatly reduced.
In summary, this study provides new insight into the changes
that occur in ILC populations within the thymus during neonatal
development. The challenge remains to determine unique in vivo
roles for these cells, particularly within nonmucosal tissues.
Materials and methods
Mice
Mice were obtained from the University of Birmingham Biomed-
ical Services Unit (BMSU) and were maintained in accordance
with Home Office regulations. All mice were on a C57BL/6 back-
ground and strains included: WT, Id2creERT2 [25] × ROSAmT/mG
[26], Id2creERT2 × ROSA26RFP [27], Id2-eGFP [28], Rorc−/- [29],
Rorccre [30] × ROSAmT/mG, and TCRα–/– [31]. Neonatal mice were
culled at day 1, 7, and 14 postbirth, and adult mice were culled
between 6 and 12 weeks of age.
In vivo procedures
Tamoxifen was administered to Id2CreERT2 × ROSAmT/mG mice
either by oral gavage (20mg/mL) once a day for five consecu-
tive days and mice culled 3 days later or within diet for 3-week
duration. Tamoxifen was administered to Id2creERT2 × ROSA26RFP
mice by oral gavage (20mg/mL) once a day for three consecutive
days and mice analyzed the following day.
Cell preparation
Thymus tissue was mechanically disaggregated between two glass
slides. mLNswere cleaned of all fat, teased apart using fine forceps,
and DNase I (0.025mg/mL, Roche Diagnostics) and collagenase
dispase (0.25mg/mL, Roche Life Sciences) were used to digest
tissue in Roswell Park Memorial Institute (RPMI). All cell sus-
pensions were passed through a 70-μm nylon strainer (Falcon R©,
Fisher scientific) using a syringe plunger.
Fetal thymic organ cultures
The embryonic sack containing stage E16 mouse embryos was
removed from a pregnant mouse following cervical dislocation.
Each embryo was decapitated and cut along the breastbone to
expose two thymic lobes, which were dissected under a light
microscope in sterile conditions. Fetal thymic organ cultures were
set up in optimal conditions as previously described by Jenkinson
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and Anderson [32]. Thymic lobes were placed on an IsoporeTM
Membrane Filter (0.8μm, Millipore) and positioned on top of a
1cm2 artiwrap sponge within a small petri dish containing 2 mL
DMEM (Sigma–Aldrich). Each petri dish was encapsulated within
a sealed container containing 10 mL of H2O and incubated for 7
days at 37°C/5% CO2. Single cell suspension from thymus tissue
was prepared as previously described.
In vitro culture for RANKL expression
Thymocytes prepared from neonatal thymi were cultured in 1
mL of culture media (RPMI, 10% FBS, L-Glutamine, 100 IU/mL
penicillin and 100 μg/mL streptomycin) overnight at 37°C/5%
CO2. Wells were set up in duplicate for each sample with each well
containing6million cells. Duplicate wells were pooled following
culture to provide a sufficient number of ILC for analysis.
Flow cytometry
Cell surface staining was performed at 4°C for 30 min in FACS
buffer (10% FBS, 2.5mMEDTA in PBS). ILCwere identified among
CD8α− (clone 5.3–6.7, Biolegend), CD3i− (clone 17A2, Biole-
gend), IL-7Rα+ (clone A7R34, Biolegend), B220− (clone RA3-
6B2, eBioscience), CD11b− (clone M1/70, eBioscience), CD11c−
(clone N418, eBioscience), CD3− (clone 145-2C11, eBioscience),
and CD5− (clone 53–7.3, eBioscience). Thymic iNKT cells were
identified as mCD1d/PBS57+ and TCRβ+ (clone H57-597, eBio-
science). Intracellular cell staining was performed at room temper-
ature for 1 h in permeabilization buffer (eBioscience). ILC2 and
ILC3 subsets were identified using Abs against GATA3+ (clone
TWAJ, eBioscience) and RORγt+ (clone AFKJS-9, eBioscience).
Staining for RANKL expression was performed in two steps using
biotinylated RANKL (clone: IK22/5, eBioscience) and streptavidin-
PECy7 (Molecular Probes) at 4°C for 30 min in FACS buffer.
Samples included Spherotech Accucount blank particles to enable
calculation of cell frequency and were acquired using a Fortessa
(BD). Samples were analyzed using FlowJo (FlowJo, LLC). Full
gating strategy for all flow cytometry data identifying thymic ILC
populations is shown in Supporting Information Fig. 1A.
Statistics
Flow cytometry data were analyzed and enumerated using FlowJo
(v10.2) and Graphpad Prism 6 (v6 Mac OS X). An unpaired,
nonparametric Mann–Whitney U statistical test was used where
applicable. Where more than 2 data sets are compared a one-way
ANOVA, nonparametric test was used. For each test, *p < 0.05,
**p < 0.01, ***p < 0.001, and ****p < 0.0001. No bar present
represents nonsignificant result.
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